最新临床试验：伊匹单抗联合或不联合纳武单抗治疗Ⅳ、Ⅲ期不能手术切除的黑色素瘤

这个随机II期临床试验，其目的是研究伊匹单抗联合或不联合纳武单抗治疗IV期或III期不能通过手术切除的黑素瘤患者的疗效。单克隆抗体，如伊匹单抗与纳武单抗，可能干扰肿瘤细胞的生长和扩散能力。

This randomized phase II trial studies how well ipilimumab with or without nivolumab work in treating patients with melanoma that is stage IV or stage III and cannot be removed by surgery. Monoclonal antibodies, such as ipilimumab and nivolumab, may interfere with the ability of tumor cells to grow and spread.

Trial Phase & Type